State Key Laboratory
for Diagnosis and Treatment of Infectious Diseases, The First Affiliated
Hospital, College of Medicine, Zhejiang University, Hangzhou 310003,
China;
Abstract：Hand, foot and mouth disease (HFMD) is an acute viral illness that primarily affects infants and young children, and often occurs in clusters or outbreaks. The major causative agents of HFMD are coxsackievirus A16 (CVA16), human enterovirus 71 (HEV71) and coxsackievirus A10 (CVA10), of the genus Enterovirus in the family Picornaviridae. HFMD caused by EV71 is associated with severe neurological complications and death. Since the late 1990s, several major epidemics of EV71 HFMD have swept through the Asia-Pacific region, associated with a rapid fulminant course, severe neurological complications, and a large number of fatalities. Until now, little has been known about the genetics and transmission trends of the fast-mutation virus, and there is no effective and specific antiviral therapy or vaccine for HFMD. It is time to step up efforts to understand the molecular epidemics and pathogenesis so that we can develop effective management strategies and surveillance programs.
Yan J J, Su I J, Chen P F, Liu C C, Yu C K, Wang J R. Complete genome analysis of enterovirus 71 isolated froman outbreak in Taiwan and rapid identification of enterovirus 71 andcoxsackievirus A16 by RT-PCR. J Med Virol, 2001, 65(2): 331–339 doi: 10.1002/jmv.2038
Bible J M, Pantelidis P, Chan P K, Tong C Y. Genetic evolution of enterovirus 71: epidemiologicaland pathological implications. Rev Med Virol, 2007, 17(6): 371–379 doi: 10.1002/rmv.538
Schmidt N J, Lennette E H, Ho H H. An apparently new enterovirusisolated from patients with disease of the central nervous system. J Infect Dis, 1974, 129(3): 304–309
Deibel R, Gross L L, Collins D N. Isolation of a new enterovirus (38506). Proc Soc Exp Biol Med, 1975, 148(1): 203–207
Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Zeipel G. Letter: New enterovirus type associated with epidemicof aseptic meningitis and-or hand, foot, and mouth disease. Lancet, 1974, 2(7872): 112 doi: 10.1016/S0140-6736(74)91684-5
Tagaya I, Tachibana K. Epidemic of hand, foot and mouth disease in Japan, 1972―1973: differencein epidemiologic and virologic features from the previous one. Jpn J Med Sci Biol, 1975, 28(4): 231–234
Gilbert G L, Dickson K E, Waters M J, Kennett M L, Land S A, Sneddon M. Outbreak of enterovirus 71 infectionin Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J, 1988, 7(7): 484–488 doi: 10.1097/00006454-198807000-00007
Shindarov L M, Chumakov M P, Voroshilova M K, Bojinov S, Vasilenko S M, Iordanov I, Kirov I D, Kamenov E, Leshchinskaya E V, Mitov G, Robinson I A, Sivchev S, Staikov S. Epidemiological, clinical, and pathomorphological characteristicsof epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol, 1979, 23(3): 284–295
Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained duringan epidemic of acute CNS diseases in Hungary in 1978. Arch Virol, 1982, 71(3): 217–227 doi: 10.1007/BF01314873
World Health Organization. Outbreak of hand, foot and mouth disease in Sarawak.Cluster of deaths among infants and young children. Wkly Epidemiol Rec, 1997, 72(28): 211–212
Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 Suppl 2: S52–57 doi: 10.1086/338819
Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. Molecular epidemiology ofenterovirus 71 infection in the Western Pacific Region. Pediatr Int, 2004, 46(2): 231–235 doi: 10.1046/j.1442-200x.2004.01868.x
AbuBakar S, Chee H Y, Al-Kobaisi M F, Xiaoshan J, Chua K B, Lam S K. Identification of enterovirus 71 isolatesfrom an outbreak of hand, foot and mouth disease (HFMD) with fatalcases of encephalomyelitis in Malaysia. Virus Res, 1999, 61(1): 1–9 doi: 10.1016/S0168-1702(99)00019-2
Lum L C, Wong K T, Lam S K, Chua K B, Goh A Y, Lim W L, Ong B B, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis, J Pediatr, 1998, 133(6): 795–798 doi: 10.1016/S0022-3476(98)70155-6
Qiu J. Viral outbreak in China tests government efforts. Nature, 2009, 458(7238): 554–555 doi: 10.1038/458554a
Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen,people's Republic of China. J Clin Microbiol, 2005, 43(8): 3835–3839 doi: 10.1128/JCM.43.8.3835-3839.2005
Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J. Enterovirus 71 outbreak in the people's Republic of China in 2008. J Clin Microbiol, 2009, 47(7): 2351–2352 doi: 10.1128/JCM.00563-09
Brown B A, Oberste M S, Alexander J P Jr, Kennett M L, Pallansch M A. Molecular epidemiology and evolution of enterovirus 71 strains isolatedfrom 1970 to 1998. J Virol, 1999, 73(12): 9969–9975
McMinn P, Lindsay K, Perera D, Chan H M, Chan K P, Cardosa M J. Phylogenetic analysis of enterovirus71 strains isolated during linked epidemics in Malaysia, Singapore,and Western Australia. J Virol, 2001, 75(16): 7732–7738 doi: 10.1128/JVI.75.16.7732-7738.2001
Tong C, Bible J. Global epidemiology of Enterovirus 71. Future Virol, 2009, 4(5): 501–510 doi: 10.2217/fvl.09.25
Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associatedwith subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267 doi: 10.1016/j.jcv.2009.02.002
Huang S C, Hsu Y W, Wang H C, Huang S W, Kiang D, Tsai H P, Wang S M, Liu C C, Lin K H, Su I J, Wang J R. Appearance of intratypic recombination of enterovirus71 in Taiwan from 2002 to 2005. Virus Res, 2008, 131(2): 250–259 doi: 10.1016/j.virusres.2007.10.002
Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus71 subgenotypes. BMC Microbiol, 2006, 6: 74 doi: 10.1186/1471-2180-6-74
Ding N Z, Wang X M, Sun S W, Song Q, Li S N, He C Q. Appearance of mosaic enterovirus 71 in the 2008 outbreakof China. Virus Res, 2009, 145(1): 157–161 doi: 10.1016/j.virusres.2009.06.006
Ho H Y, Cheng M L, Weng S F, Chang L, Yeh T T, Shih S R, Chiu D T. Glucose-6-phosphatedehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol, 2008, 89(Pt 9): 2080–2089 doi: 10.1099/vir.0.2008/001404-0
Chang L Y, Chang I S, Chen W J, Huang Y C, Chen G W, Shih S R, Juang J L, Shih H M, Hsiung C A, Lin T Y, Huang L M. HLA-A33 is associated with susceptibility to enterovirus71 infection. Pediatrics, 2008, 122(6): 1271–1276 doi: 10.1542/peds.2007-3735
Huemer H P, Ortner B, Huang C W, Schmid D, Mutz I, Wewalka G, Yang J Y, Allerberger F. Isolating Asian enterovirus71 subgenogroup C4 in two Austrian clinical samples from 2004. Euro Surveill, 2008, 13(28): pii: 18922
Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associatedwith subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267 doi: 10.1016/j.jcv.2009.02.002
Qiu J. Enterovirus 71 infection: a new threat to global publichealth? Lancet Neurol, 2008, 7(10): 868–869 doi: 10.1016/S1474-4422(08)70207-2
Chen L C, Shyu H W, Chen S H, Lei H Y, Yu C K, Yeh T M. Enterovirus 71 infection induces Fas ligand expressionand apoptosis of Jurkat cells. J Med Virol, 2006, 78(6): 780–786 doi: 10.1002/jmv.20623
Chang S C, Lin J Y, Lo L Y, Li M L, Shih S R. Diverse apoptotic pathwaysin enterovirus 71-infected cells. J Neurovirol, 2004, 10(6): 338–349 doi: 10.1080/13550280490521032
Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus71. Nat Med, 2009, 15(7): 798–801 doi: 10.1038/nm.1992
Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoproteinligand-1 is a functional receptor for enterovirus 71. Nat Med, 2009, 15(7): 794–797 doi: 10.1038/nm.1961
Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 (Suppl 2): S52–57 doi: 10.1086/338819
Chang L Y, Hsia S H, Wu C T, Huang Y C, Lin K L, Fang T Y, Lin T Y. Outcome of enterovirus 71 infections with or without stage-based management:1998 to 2002. Pediatr Infect Dis J, 2004, 23(4): 327–332 doi: 10.1097/00006454-200404000-00010
Chang L Y, Lin T Y, Hsu K H, Huang Y C, Lin K L, Hsueh C, Shih S R, Ning H C, Hwang M S, Wang H S, Lee C Y. Clinical features and risk factors of pulmonary oedemaafter enterovirus-71-related hand, foot, and mouth disease. Lancet, 1999; 354(9191): 1682–1686 doi: 10.1016/S0140-6736(99)04434-7
Wang S M, Lei H Y, Huang M C, Su L Y, Lin H C, Yu C K, Wang J L, Liu C C. Modulation of cytokine production byintravenous immunoglobulin in patients with enterovirus 71-associatedbrainstem encephalitis. J Clin Virol, 2006, 37(1): 47–52 doi: 10.1016/j.jcv.2006.05.009
Wang S M, Lei H Y, Huang M C, Wu J M, Chen C T, Wang J N, Wang J R, Liu C C. Therapeutic efficacy of milrinone inthe management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol, 2005, 39(3): 219–223 doi: 10.1002/ppul.20157
Chen T C, Weng K F, Chang S C, Lin J Y, Huang P N, Shih S R. Development of antiviral agents for enteroviruses. J Antimicrob Chemother, 2008, 62(6): 1169–1173 doi: 10.1093/jac/dkn424
Pevear D C, Tull T M, Seipel M E, Groarke J M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother, 1999, 43(9): 2109–2115
Shia K S, Li W T, Chang C M, Hsu M C, Chern J H, Leong M K, Tseng S N, Lee C C, Lee Y C, Chen S J, Peng K C, Tseng H Y, Chang Y L, Tai C L, Shih S R. Design, synthesis, and structure-activityrelationship of pyridyl imidazolidinones: a novel class of potentand selective human enterovirus 71 inhibitors. J Med Chem, 2002, 45(8): 1644–1655 doi: 10.1021/jm010536a
Li Z H, Li C M, Ling P, Shen F H, Chen S H, Liu C C, Yu C K. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viralreplication. J Infect Dis, 2008, 197(6): 854–857 doi: 10.1086/527326
Foo D G, Alonso S, Phoon M C, Ramachandran N P, Chow V T, Poh C L. Identification of neutralizinglinear epitopes from the VP1 capsid protein of Enterovirus 71 usingsynthetic peptides. Virus Res, 2007, 125(1): 61–68 doi: 10.1016/j.virusres.2006.12.005
Chen H L, Huang J Y, Chu T W, Tsai T C, Hung C M, Lin C C, Liu F C, Wang L C, Chen Y J, Lin M F, Chen C M. Expression of VP1 protein in the milk of transgenic mice:a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 2008, 26(23): 2882–2889 doi: 10.1016/j.vaccine.2008.03.041
Ooi M H, Solomon T, Podin Y, Mohan A, Akin W, Yusuf M A, del Sel S, Kontol K M, Lai B F, Clear D, Chieng C H, Blake E, Perera D, Wong S C, Cardosa J. Evaluation of different clinical sample types in diagnosis of human enterovirus71-associated hand-foot-and-mouth disease. J Clin Microbiol, 2007, 45(6): 1858–1866 doi: 10.1128/JCM.01394-06
Perez-Velez C M, Anderson M S, Robinson C C, McFarland E J, Nix W A, Pallansch M A, Oberste M S, Glode M P. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007, 45(8): 950–957 doi: 10.1086/521895
Ooi M H, Wong S C, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng C H, Tio P H, Cardosa M J, Solomon T. Identification and validationof clinical predictors for the risk of neurological involvement inchildren with hand, foot, and mouth disease in Sarawak. BMC Infect Dis, 2009, 9: 3 doi: 10.1186/1471-2334-9-3
Chen K T, Chang H L, Wang S T, Cheng Y T, Yang J Y. Epidemiologic features ofhand-foot-mouth disease and herpangina caused by enterovirus 71 inTaiwan, 1998―2005. Pediatrics, 2007, 120(2): e244–252 doi: 10.1542/peds.2006-3331
Podin Y, Gias E L, Ong F, Leong Y W, Yee S F, Yusof M A, Perera D, Teo B, Wee T Y, Yao S C, Yao S K, Kiyu A, Arif M T, Cardosa M J. Sentinel surveillance for human enterovirus 71 in Sarawak,Malaysia: lessons from the first 7 years. BMC Public Health, 2006, 6: 180 doi: 10.1186/1471-2458-6-180
Chen S C, Chang H L, Yan T R, Cheng Y T, Chen K T. An eight-year study of epidemiologicfeatures of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg, 2007, 77(1): 188–191
